We have demonstrated that rat liver contains at least four types of sialidase differing in subcellular location, in catalytic property and immunologically. They are intralysosomal, cytosolic and membraneassociated sialidases I and II. Membrane sialidase I locates mainly in plasma membrane and sialidase II in lysosomal membrane. Immunological study reveals that the same types of sialidase exist in various tissues of rat and of other mammalian species. Based on these results, we examined the sialidases in rat hepatomas and in transformed cells of JB6 mouse epidermal cell. Hepatomas were found to possess four types of sialidase and the three of them altered quantitatively. Intralysosomal sialidase activity was higher but cytosolic and lysosomal membrane sialidase activities were lower in hepatomas than in control liver. When the sialidases of transformants of JB6 cells were compared with those of control cells, the activities of two lysosomal sialidases were decreased and contrarily plasma membrane sialidase was increased. We discussed a possible significance of the sialidase alterations in carcinogenesis.
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sialidases ; carcinogenesis ; hepatoma ; neoplastic alteration ; subcellular localization Sialic acids are generally found in the terminal position of the carbohydrate groups of glycolipids and glycoproteins. They have been proposed to play important roles in many biological processes by influencing conformation of glycoproteins, recognizing and masking biological sites of the molecules and cells (Schauer 1985) : for example, the removal of sialic acids results in a rapid clearance of serum glycoproteins from blood circulation and in alterations of recognition by receptors and of antigenic expression. Sialic acid transfer by sialyltransferase mostly terminates the sugar elongation and sialic acid removal by sialidase initiates the break-down of sugar chains.
The carbohydrate portion of glycoproteins and glycolipids is known to undergo neoplastic alterations (Warren et al. 1978; Hakomori et al. 1989 ) . In particular, alterations of sialic acids may be associated with cancer phenotypes Address for reprints : 4-1 Seiryomachi, Aoba-ku, Sendai 980 , Japan. 223 such as decreased adhesiveness and metastatic potential. Recent report (Santer et al. 1989 ) has clearly presented the evidence that sialylation in highly branched N-glycan structure is required for oncogenic transformation.
To elucidate how aberrant sialylation occurs in cancer cells, we have been studying neoplastic alterations of sialidase and sialyltransferase.
In this report, we demonstrate multiple forms of mammalian sialidase and investigate their alterations in carcinogenesis by using two tumor models : rat hepatomas and transformed cell lines of JB6 mouse epidermal cells.
MATERIALS AND METHODS

Cells, tissues and hepatomas
Parental JB6 cells were kindly supplied by Colburn et al. and grown under the conditions described previously (Miyagi et al. 1990d ). Transformation of JB6 cells was induced by phorbol ester, 12-0-tetradecanoyl phorbol-l3-acetate (TPA). To examine the effect of TPA, the cells were exposed to 10 mg/ml of TPA for 24 hr then harvested. Anchorage-independent clones were isolated by plating on the surface of 0.5% agar plate containing TPA.
Normal rat tissues were obtained from male Wistar rats fed ad libitum and regenerating liver was from partially hepatectomized male Wistar rats 24 hr and 48 hr after operation. Primary hepatocellular carcinoma was induced in male Wistar rats by feeding them with 3'-methyl-4-dimethylaminoazobenzene (Me-DAB). Transplantable AH-109A hepatoma was inoculated into male Donryu rats subcutaneously and harvested 12-14 days later. The detailed procedures are described elsewhere (Miyagi et al. 1990a ).
Chemical compounds
Sialidase substrates and all other compounds were available from previous works Tsuiki 1985, 1986 ).
Sialidase preparations
Cells were sonicated in 0.25 M sucrose, l mM EDTA and tissues were homogeized in the sucrose solution using a glass-Teflon homogenizer. The homogenate was centrifuged at 600 X g for 10 min and the supernatant was centrifuged at 105,000 X g for 1 hr. The resulting pellet and supernatant were used as the particulate and cytosolic fractions, respectively. Solubilization of membrane-associated sialidases was conducted by adding deoxycholate and Tritonx-100 to the particulate fraction.
Intralysosomal sialidase was partially purified from the particulate fraction of rat liver as described previously (Miyagi and Tsuiki 1984) . Cytosolic sialidase was purified homogeneously from the cytosolic fractions of rat liver or skeletal muscle accordng to the method described in the previous work (Miyagi and Tsuiki 1985) . The solubilization and partial purification of membrane sialidases I and II was conducted using rat brain or liver as an enzyme source as described previously (Miyagi et al. 1990b ).
Sialidase assay
The standard assay mixture contained 50-150 nmol (as bound sialic acid) of substrate, 0.2 mg bovine serum albumin, 15,umol of buffer and enzyme in 0.2 ml. 4-Methylumbelliferyl-a-n-N-acetylneuramimic acid (4MU-NeuAc) was routinely used as substrate for intralysosomal and cytosolic sialidases, and ganglioside GM3 for membrane sialidases I and II. Cytosolic sialidase was assayed in sodium cacodylate, pH 6.0 and the other three sialidases in sodium acetate, pH 4.7. After incubation at 37°C for 30-180 min, 4MU released from 4MTT-NeuAc or sialic acid released from natural substrated was deter-mined. The detailed procedure was described previously (Miyagi and Tsuiki 1985) .
Immunological studies
Three antibodies were produced against cytosolic sialidase (Miyagi et al. 1990c ) and membrane sialidases I and II (Miyagi et al. 1990b ) in rabbits. The antisera obtained were used for immunoprecipitation test as described elsewhere (Miyagi et al. 1990c ).
RESULTS AND DISCUSSION Multiple forms of rat sialidase
Although sialidases from various mammalian sources have been reported, less information is available on their properties than viral and bacterial enzymes primarily due to their instability, low activity and membrane-bound character. During the course of our attempts to solubilize and purify rat liver sialidase, we demonstrated that rat liver contained at least four types of sialidase differing in subcellular location, catalytically and chromatographically as shown in Table 1 . They are intralysosomal, cytosolic and membrane-associated sialidases I and II.
When rat liver homogenates were fractionated by differential centrifugation, the resulting fractions exhibited sialidase activity toward sialyllactose, 4MU-NeuAc and gangliosides. With sialyllactose or 4MU-NeuAc as substrate, more than 60% of the sialidase activity obtained at pH 4.5 was found in the mitochondrial and lysosomal fractions while the activity at pH 6.0 was in the postmicrosomal supernatant to the extent of 70%. These data suggest that rat liver contains cytosolic sialidase in addition to the sialidase present in the mitochondrial and lysosomal fractions, which has been thought to be a major sialidase (Mahadevan et al. 1967; Harvat and Touster 1968) .
Lysosomes isolated from rat liver were found to be capable of removing sialic acids from all the sialic acid-containing materials tested. When the lysosomes were subjected to hypotonic disruption followed by centrifugation, however, the major activity toward sialyllactose was in the supernatant and the activities toward gangliosides and submaxillary mucins were in the pellet. These data indicated a possible existence of two types of sialidase in lysosomes.
To gain further information on the sialidases present in the cytosol and in the lysosomal matrix, we attempted to purify the sialidases from the respective fractions. The sialidase in the lysosomal matrix was partially purified by Sephadex G-200 followed by CM-cellulose, and the enzyme showed narrow substrate specificity such that only oligosaccharides and glycopeptides could be hydrolyzed. The sialidase found in the cytosol could be purified homogeously by sequential chromatography on DEAF-cellulose, CM-cellulose, Blue-Sepharose, Sephadex G-200, and heparin-Sepharose. In contrast to the intralysosomal sialidase, the cytosolic enzyme was active toward all of oligosaccharides, glycoproteins and gangliosides tested except for submaxillary mucins and GM1 and 0M2 gangliosides.
To investigate membrane-associated sialidases including sialidase locating in the lysosomal membrane, sialidase activity was solubilized with Triton X-100 plus sodium deoxycholate from membraneous structures. When the solubilized activity from rat liver or brain particulate was chromatographed on AH-Sepharose, the activity was resolved into two peaks, which were designated sialidases I and II in order of elution. Two sialidases were separately purified by using sequential chromatography on Octyl-Sepharose, Phenyl-Sepharose, Sephadex G-200 and Mono Q. Membrane sialidase I hydrolyzed gangliosides but scarcely other substrates, while membrane sialidase II hydrolyzed oligosaccharides, glycoproteins and 4MU-NeuAc as well as gangliosides. Sialidase I was found to locate mainly in plasma membrane and sialidase II in lysosomal membrane by examining sialidase in the membranes isolated.
To obtain further evidence that four types of sialidase are proteins distinct from one another, antibodies were raised against cytosolic sialidase and membrane sialidases I and II. The antibodies were entirely specific for the sialidase that served as immunogen, and were able to differentiate the four types of sialidase (Table 1) . Using the antibodies, we also found these sialidases widely distributed in various tissues of rat, mouse, bovine and human.
No evidence clarifying the physiological function of the sialidases can be offered at present. However, the finding that these sialidases are distinct proteins and thus probably the products of distinct genes supports our hypothesis that each one plays a unique role depending on its unique subcellular location and catalytic property. For example, intralysosomal sialidase may participate in glycoprotein catabolism by collaborating with lysosomal proteases since cleavage by this sialidase is required prior to fragmentation of a protein core by proteases. Similarly, membrane sialidase II is likely to be engaged in lysosomal catabolism of gangliosides. In contrast to these lysosomal sialidases, cytosolic sialidase may be engaged in regulatory desialylation because of its ability to act on native glycoproteins at neutral pH. Membrane sialidase I may be involved in the regulation of cell growth by modifying the membrane gangliosides since gangliosides are known to function as modulators for cell growth (Hakomori 1990 ).
Neoplastic alterations of sialidase Based on the multiple nature of rat liver sialidase, the sialidases of rat hepatomas were compared with those of control liver ( Table 2) . McDAB-induced hepatoma showed higher activity of intralysosomal sialidase and lower activities of membrane sialidase I and cytosolic sialidase than control liver, whereas the level of membrane sialidase I was unchanged. These hepatoma sialidases could be purified in accordance with the procedures of corresponding rat liver sialidases. They were indistinguishable from the liver enzymes in chromatographic behavior, in catalytic properties and immunologically. Quantitative changes similar to those seen in DAB-hepatoma were found in AH-109A hepatomas. It is of intrest that unlike hepatomas, regenerating liver reduced membrane sialidase I significantly although the other types of sialidase showed alterations similar to hepatomas. The significance of the alteration upon hepatocarcinogenesis is not known, but it is conceivable that the decrease in lysosomal membrane sialidase and cytosolic sialidase, which was obserbed in both of hepatomas and regenerating liver, may brings about hypersialylation of glycoproteins because of their capability of attacking intact glycoproteins. To know whether these alterations seen in hepatocarcinogenesis also occur in other types of cancer cells, we studied sialidase activity in JB6 mouse epidermal cells before and after exposure TPA, which irreversibly induces anchorageindependent growth and tumorgenicity (Colburn et al. 1978 (Colburn et al. , 1979 . The results are shown in Table 3 . JB6 cells exhibited sialidase activities toward 4MU-NeuAc and gangliosides at pH 4.7 in the particulate fraction but apparently not in the cytosol. In JB6 cells exposed to TPA and in the anchorage-independent transformants, the sialidase activity toward 4MU-NeuAc was decreased and the sialidase activity toward gangliosides was increased compared with those in untreated JB6 cells. Immunological analysis with antisera against membrane-associated sialidases I and II showed that plasma membrane sialidase I was increased and lysosomal membrane sialidase II was decreased. Since membrane sialidase II but not membrane sialidase I was strongly reduced in hepatoma as compared with normal liver (Table 2) , a decrease in the ratio of membrane sialidase II to I may be a change occuring independently of cell origin and in the pathway of tumor induction. The observation by Schengrund et al. (1973) that the activity of ganglioside sialidase appeared in BHK transformed cells is consistent with the present study, although no information is presently available for identification of their sialidase as our sialidase I. If it is true that a major function of membrane sialidase I may be to modify the cell surface gangliosides, the present results suggest that modification of cell surface gangliosides occurs actively in tumors. Elucidation of the structures an expression mechanisms of the sialidases will clarify the significance of the sialidase alterations in carcinogenesis. 
